[Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D006953:Hyperlipoproteinemia Type IV / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D000960:Hypolipidemic Agents; C009746:etofibrate; D002995:Clofibric Acid; D002994:Clofibrate
Studio a doppio cieco sull'attività terapeutica di un nuovo farmaco ipolipemizzante: l'etofibrato.